Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2007
10/03/2007EP1838734A2 Antibodies against antigen presenting cells and uses thereof
10/03/2007EP1838667A2 2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses
10/03/2007EP1838347A1 Pharmaceutical compositions for treating diseases associated with nf-kappab activity
10/03/2007EP1838345A2 Saccharide conjugate vaccines
10/03/2007EP1838327A1 Treatment of defects of cellular immunity with leukocyte homogenates having a molecular weight of less than 10,000 dalton
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1366161B1 Antagonist anti-pro842 antibody
10/03/2007EP1353672B1 Synthesis of 4-amino-thalidomide enantiomers
10/03/2007EP1309339B1 Stimulating neutrophil function to treat inflammatory bowel disease
10/03/2007EP1307458B1 Pyrrolotriazolopyrimidinone derivatives
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1227840B1 Adjuvanted genetic vaccines
10/03/2007EP1187916B1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
10/03/2007EP1135482B1 Cancer cell vaccine
10/03/2007EP1100942B1 Herpes virus vectors for dendritic cells
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions
10/03/2007CN101048497A Method for acquiring and applying needed raw material for reccogniting self antigen immunity
10/03/2007CN101048167A Immune stimulatory infant nutrition
10/03/2007CN101048160A Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
10/03/2007CN101045745A Scale preparation method of bursin and application of used as avian influema vaccine adjuvant
10/03/2007CN101045161A Modulators of P-selectin glycoprotein ligand 1
10/03/2007CN101045148A Ointment for treating anaphylactic and its producing method
10/03/2007CN101045131A Health-care capsule with functions of anti-fatigue and regulating immunity
10/03/2007CN101045095A Traditional Chinese medicine capsul for treating rhinitis
10/03/2007CN101045073A Method for preparing extractive of liuyueqing and its application
10/03/2007CN101045060A External use medicine containing tetramethylpyrazine GC glucocorticoid with its skin side-effects reducing obviously
10/03/2007CN101045040A Wrapped tablets dichlororeytadin and its preparing method
10/03/2007CN101044884A Method for prepairng feed additives containing yolk anti body
10/03/2007CN100340561C Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340551C 4-(diarylmethyl)-1-piperazinyl derivatives
10/03/2007CN100340289C Method to enhance an immune response of nucleic acid vaccination
10/03/2007CN100340244C Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/02/2007US7276593 Proteins and nucleic acids encoding same
10/02/2007US7276524 Compounds as antumor agents or immunosuppressants
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276515 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases
10/02/2007US7276513 Steroidal compounds for inhibiting steroid sulphatase
10/02/2007US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic
10/02/2007US7276505 Immunomodulating heterocyclic compounds
10/02/2007US7276502 For therapy and prophylaxis of immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, proliferative disorders, immunologically-mediated diseases, or respiratory disorders
10/02/2007US7276500 Substituted amides, their preparation and use
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276234 Introducing a fetal immature T lymphocyte transfected with the foreign DNA into a thymus that has been radiated to transiently suppress T lymphocytes, and expressing the foreign DNA in the thymus during differentiation and maturation of the fetal immature T lymphocyte to reconstitute the immune system
10/02/2007CA2412564C Purine derivatives
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2289509C Novel compounds
10/02/2007CA2168583C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
10/02/2007CA2027341C Process for the preparation of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives
09/2007
09/28/2007CA2550986A1 Drug and/or food supplement containing nisylen, cepa, eurphrasia, belladonna and/or mercurius solubilis
09/27/2007WO2007109813A1 Imidazoquinoxaline compounds as immunomodulators
09/27/2007WO2007109686A2 Immunomodulation of inflammatory conditions utilizing follistatin-like protein-1 and agents that bind thereto
09/27/2007WO2007109330A2 S1p receptor modulating compounds
09/27/2007WO2007109238A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
09/27/2007WO2007108764A2 Thermostable lactobacillus strains
09/27/2007WO2007108763A1 Use of lactobacillus strains for promoting immunotolerance in autoimmune disease
09/27/2007WO2007108750A1 Pyridopyrimidine derivatives and their use as pde4 inhibitors
09/27/2007WO2007108633A1 A pharmaceutical composition for the treatment or prevention of allergic diseases, use thereof, and a method for treatment or prevention of allergic diseases
09/27/2007WO2007108042A1 Antiinflammatory agent
09/27/2007WO2007107598A1 Phosphorylated a2a receptor agonists
09/27/2007WO2007107499A1 Quinoline derivatives useful as pde4 inhibitors
09/27/2007WO2007107318A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders
09/27/2007WO2007084557A3 Azaindoles useful as inhibitors of janus kinases
09/27/2007US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
09/27/2007US20070225356 Preventive and/or Therapeutic Agent for Chronic Sinusitis
09/27/2007US20070225321 2,4-pyrimidinediamine compounds and their uses
09/27/2007US20070225303 8-Oxoadenine Compound
09/27/2007US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
09/27/2007US20070225218 Extracellular Messengers
09/27/2007US20070224279 Stabilization of chemical compounds using nanoparticulate formulations
09/27/2007US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists
09/27/2007US20070224214 Composition Exerting Physiological Activity Via Biological Immune Mechanism
09/27/2007US20070224187 Method of treating a pathological syndrome and a pharmaceutical agent
09/27/2007DE102006014165A1 Neue Isooxazol-Derivate und deren Verwendungen New isoxazole derivatives and uses thereof
09/27/2007CA2646958A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
09/27/2007CA2646539A1 Imidazoquinoxaline compounds as immunomodulators
09/27/2007CA2646469A1 S1p receptor modulating compounds
09/27/2007CA2644207A1 Pharmaceutical combination composition comprising at least one pkc inhibitor and at least one jak3 kinase inhibitor for treating autoimmune disorders
09/26/2007EP1837330A1 Benzamide inhibitors of the P2X7 receptor
09/26/2007EP1837031A1 Compositions and methods for treating diabetes
09/26/2007EP1837027A1 Iridoid glycoside composition
09/26/2007EP1837017A2 Microparticles for delivery of nucleic acid
09/26/2007EP1836226A1 Antibodies against il-13 receptor alpha 1 and uses thereof
09/26/2007EP1836225A1 Kir-binding agents and methods of use thereof
09/26/2007EP1836216A1 Binding partners of antibodies specific for dendritic cell antigens
09/26/2007EP1836215A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
09/26/2007EP1836209A1 Crystalline forms of6-[(5s,9r)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl]nicotinic acid as inhibitors of cd18 integrins, icams and/or the lfa-1:icam interaction for the treatment of inflammations and immune diseases
09/26/2007EP1835930A1 Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
09/26/2007EP1835922A1 Combination treatment for multiple sclerosis
09/26/2007EP1835915A2 Immune response modifier formulations and methods
09/26/2007EP1835889A1 Nanoparticulate tacrolimus formulations
09/26/2007EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
09/26/2007EP1438040B1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
09/26/2007EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c
09/26/2007EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
09/26/2007EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
09/26/2007EP1391464B1 Anti-cd40 monoclonal antibody
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
1 ... 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 ... 1172